Radx tech project #2620 accelerated manufacturing scale-up for ANP technologies' nano-intelligent detection system(nids)covid-19 antigen rapid test
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92021C00005
- Awardee
-
ANP Technologies Inc. UEI PNL1U1FNPLF9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,327,817
Award facts
- Contract value 100% obligated
- $19,327,817.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Newark, DE, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Close Out | -$400,000 | |
| Other Administrative Action | $0 | |
| Definitize Letter Contract | $11,836,690 | |
| Original award | $7,891,127 |
About this award
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $19.3 million firm fixed price definitive contract to ANP Technologies Inc. to support the RADX TECH PROJECT #2620 for accelerated manufacturing scale-up of ANP Technologies' nano-intelligent detection system for COVID-19 antigen rapid testing. Performance will take place in Newark, Delaware over a two year period concluding in December 2022. No set aside designation or subcontractors were indicated. This contract provides funding for ANP Technologies to expand production of its Nano-Intelligent Detection System, which can rapidly test for COVID-19 antigens, supporting the National Institutes of Health's ongoing efforts to address the COVID-19 pandemic through diagnostic technology development.
Quick answers
Who was awarded contract 75N92021C00005?
75N92021C00005 was awarded to ANP Technologies Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on December 11, 2020.
How much is contract 75N92021C00005 worth?
The government has obligated $19,327,817 on 75N92021C00005.
Was contract 75N92021C00005 competed?
The extent of competition for 75N92021C00005 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award